CareersInvestorsPressCorporate
Login
  1. Home
  2. Medical Imaging
  3. Mammography
  4. Clinical Corner
  5. Mammography – Case studies
  6. Breast Cancer Imaging at Schwarzer Bär Hanover

Breast Cancer Imaging at Schwarzer Bär, Hanover Next-generation mammography transforms the daily practice for radiologists, technologists, and patients.

2023-11-01

Mammography Screening Hanover was one of the first clinics to install the next-generation MAMMOMAT B.brilliant. 

Located at Schwarzer Bär in Hanover, the clinic is committed to diagnostic clarity - excluding the maybes from breast cancer imaging with advanced technology. 

The new system has made a positive difference, and the practice staff share their insights. This page at a glance: 

  • The challenges facing the practice 
  • The difference for the radiologists 
  • The difference for technologists and patients 
  • The technology behind the solution

The challenges facing the practice

Clinic signage announces Mammography Screening Hannover in Germany

How to accurately diagnose 1,250 women per week
High patient volume means the team is always working against the clock. For radiologists like Regine Rathmann, this makes consistent diagnostic accuracy a challenge and it can also impact staff training and motivation. For the practice mammographers, it can be difficult to work efficiently and still maintain well-being – both their patients’ and their own.

See the difference MAMMOMAT B.brilliant has made at this high-volume practice.

The difference for the radiologists

"Ever since I took part in the ToSyMa study, I have believed in the potential of tomosynthesis imaging to reduce breast cancer mortality. With MAMMOMAT B.brilliant, the image quality is very impressive and exam times shorter, which to me confirms that this latest iteration of tomosynthesis technology is suitable for high-volume screening."
Regine Rathmann
Regine Rathmann
Radiologist in charge of screening at Mammography Screening Hanover, Germany

Recall cases indicate the new system’s suitability for screening
After initial, narrow-angle screenings proved inconclusive, MAMMOMAT B.brilliant delivered the enhanced image quality required for a confident and accurate diagnosis.

1/3

Clinical case 1 
51-year-old woman, first round of screening, no prior images, recalled for microcalcifications in the right breast. 

With MAMMOMAT B.brilliant 

  • microcalcifications appear sharp 
  • clear evaluation of the extent of the microcalcification cluster
1/3

The difference for technologists and patients

"The new system makes it easy for me to position the patient and the 45° method is also more ergonomic for our backs. Something else – the tomo scan time is really very good. It shortens the exam time for the patients and makes our job easier, too."
Diana Jungton
Diana Jungton
Mammographer at Mammography Screening 
Hanover, Germany

Watch Diana’s assessment
In this clip, mammographer Diana shares her insights after working for six months with MAMMOMAT B.brilliant.

High-speed scanning and improved ergonomics have made MAMMOMAT B.brilliant a popular addition to the practice – with mammographers and patients alike …

The patient’s perspective
Watch this clip to find out how MAMMOMAT B.brilliant affected one patient’s well-being.

MAMMOMAT B.brilliant helps rule out the maybes.

It helps to improve diagnostic accuracy, scan speed, and ease of use. How? With ground-breaking technology ...

MAMMOMAT B.brilliant Key Visual

Exclude the maybes from breast cancer imaging

Learn how MAMMOMAT B.brilliant can enhance the reputation of your breast cancer imaging practice with cutting-edge technology that priortizes early detection, patient comfort, and radiographer efficiency.

MAMMOMAT B.brilliant is not commercially available in all countries. Its future availability cannot be guaranteed.
The statements by Siemens’ Healthineers customers described herein are based on results that were achieved in the customer's unique setting. Because there is no "typical" hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.
1
Data on file
2
Data on file; for average breast size of 50/50 glandular/adipose tissue and 5 cm thickness.
3
Maldera A, De Marco P, Colombo PE, Orrigi D, Torresein A. Digital breast tomosynthesis: Dose and image quality assessment. Phys Med. 2017; 33: 56–67.
4
Compared to MAMMOMAT Revelation.
5
Compared to FFDM. Cancer detection rate was 43% higher for invasive cancers in a large prospective screen trial of 15,000 women. Zackrisson S, Lång K, Rosso A, Johnson K, Dustler M, Förnvik D et al. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): A prospective, population-based, diagnostic accuracy study. The Lancet Oncology. 2018; 19(11): 1493–503. doi:10.1016/S1470-2045(18)30521-7.
6
“One-view tomo only” is not FDA approved in the U.S.